Non-pegylated and Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma and the Risk of Severe Ocular Side-effects

Acta Derm Venereol. 2022 May 24:102:adv00722. doi: 10.2340/actadv.v102.2487.

Authors

Jana D Albrecht, Nadia Ninosu, Denise Barry, Thomas Albrecht, Marthe-Lisa Schaarschmidt, Sergij Goerdt, Jan P Nicolay¹

Affiliation

¹ Department of Dermatology, Venereology and Allergology, University Medical Center Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, DE-68167 Mannheim, Germany. jan.nicolay@umm.de.

No abstract available

MeSH terms

Antiviral Agents / therapeutic use
Humans
Interferon-alpha / adverse effects
Lymphoma, T-Cell, Cutaneous* / diagnosis
Lymphoma, T-Cell, Cutaneous* / drug therapy
Polyethylene Glycols / adverse effects
Recombinant Proteins / adverse effects
Skin Neoplasms* / drug therapy

Substances

Antiviral Agents
Interferon-alpha
Recombinant Proteins
Polyethylene Glycols